Spectrum Pharmaceuticals, Inc. (SPPI) Announces Third Quarter 2012 Financial Results Teleconference and Webcast  
10/31/2012 7:49:25 AM

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced it will host a teleconference and webcast with management to discuss the third quarter 2012 financial results, provide an update on the Company's business, and discuss expectations for the future.